Amae Health Raises $25M in Series B Round

Why It Matters

The funding accelerates scaling of an AI‑enhanced outpatient mental‑health model, which could lower costly rehospitalizations and address a sizable unmet need in the U.S. mental‑health market.

Deal Summary

Amae Health, a public benefit corporation focused on outpatient treatment for severe mental illness, announced a $25 million pre‑empted Series B financing led by Altos Ventures. Existing investors Quiet Capital, Bling Capital, Cedars‑Sinai Ventures, Healthier Capital and 8VC also participated, bringing total funding to over $50 million.